Home › Geographic Atrophy › Utah
Geographic Atrophy clinical trials in Utah
4 studies for Geographic Atrophy are looking for participants at sites in Utah.
Cities in Utah
A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Retina Research Center of Southern Utah, St. George
RecruitingPhase 1/2
Ages 55 and older · All sexes · Updated Sep 23, 2026 · NCT07029945A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Retina Associates Of Utah Retina Specialist, Salt Lake City
- Rocky Mountain Retina Consultants, Salt Lake City
- Salt Lake Retina- Ophthalmology, West Jordan
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 18, 2026 · NCT06541704A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- University of Utah, Salt Lake City
RecruitingPhase 2/3
Ages 60 and older · All sexes · Updated Sep 14, 2026 · NCT06635148Progression of Early Atrophic Lesions
- University of Utah, Salt Lake City
RecruitingObservational study
Ages 50 and older · All sexes · Updated Mar 11, 2026 · NCT05959005From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.